1932

Abstract

Selection and validation of novel molecular targets have become of paramount importance in light of the plethora of new potential therapeutic drug targets that have emerged from human gene sequencing. In response to this revolution within the pharmaceutical industry, the development of high-throughput methods in both biology and chemistry has been necessitated. This review addresses these technological advances as well as several new areas that have been created by necessity to deal with this new paradigm, such as bioinformatics, cheminformatics, and functional genomics. With many of these key components of future drug discovery now in place, it is possible to map out a critical path for this process that will be used into the new millennium.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.pharmtox.40.1.177
2000-04-01
2024-04-19
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.pharmtox.40.1.177
Loading
/content/journals/10.1146/annurev.pharmtox.40.1.177
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error